Search

Your search keyword '"Paul H. Lange"' showing total 13 results
Start Over Author "Paul H. Lange" Journal journal of the national comprehensive cancer network : jnccn
13 results on '"Paul H. Lange"'

1. NCCN Clinical Practice Guidelines Prostate Cancer Early Detection, Version 2.2015

Author

Peter R, Carroll, J Kellogg, Parsons, Gerald, Andriole, Robert R, Bahnson, Daniel A, Barocas, Erik P, Castle, William J, Catalona, Douglas M, Dahl, John W, Davis, Jonathan I, Epstein, Ruth B, Etzioni, Thomas, Farrington, George P, Hemstreet, Mark H, Kawachi, Paul H, Lange, Kevin R, Loughlin, William, Lowrance, Paul, Maroni, James, Mohler, Todd M, Morgan, Robert B, Nadler, Michael, Poch, Chuck, Scales, Terrence M, Shaneyfelt, Marc C, Smaldone, Geoffrey, Sonn, Preston, Sprenke, Andrew J, Vickers, Robert, Wake, Dorothy A, Shead, and Deborah, Freedman-Cass

Subjects
Diagnostic Imaging, Male, Biopsy, Humans, Mass Screening, Prostatic Neoplasms, Biomarkers, Early Detection of Cancer
Abstract

Prostate cancer represents a spectrum of disease that ranges from nonaggressive, slow-growing disease that may not require treatment to aggressive, fast-growing disease that does. The NCCN Guidelines for Prostate Cancer Early Detection provide a set of sequential recommendations detailing a screening and evaluation strategy for maximizing the detection of prostate cancer that is potentially curable and that, if left undetected, represents a risk to the patient. The guidelines were developed for healthy men who have elected to participate in the early detection of prostate cancer, and they focus on minimizing unnecessary procedures and limiting the detection of indolent disease.

Published
2015

2. NCCN clinical practice guidelines in oncology: prostate cancer

Author

James, Mohler, Robert R, Bahnson, Barry, Boston, J Erik, Busby, Anthony, D'Amico, James A, Eastham, Charles A, Enke, Daniel, George, Eric Mark, Horwitz, Robert P, Huben, Philip, Kantoff, Mark, Kawachi, Michael, Kuettel, Paul H, Lange, Gary, Macvicar, Elizabeth R, Plimack, Julio M, Pow-Sang, Mack, Roach, Eric, Rohren, Bruce J, Roth, Dennis C, Shrieve, Matthew R, Smith, Sandy, Srinivas, Przemyslaw, Twardowski, and Patrick C, Walsh

Subjects
Male, Prostatectomy, Early Diagnosis, Life Expectancy, Radiotherapy, Humans, Lymph Node Excision, Prostatic Neoplasms, Androgen Antagonists, Prostate-Specific Antigen, Medical Oncology
Published
2010

3. Kidney cancer. Clinical practice guidelines

Author

Robert J, Motzer, Michael A, Carducci, Mayer, Fishman, Steven L, Hancock, Ralph J, Hauke, Gary R, Hudes, Philip, Kantoff, Timothy M, Kuzel, Paul H, Lange, Ellis G, Levine, Chris, Logothetis, Kim A, Margolin, Roberto, Pili, Kamal S, Pohar, Bruce G, Redman, Sylvia, Richey, Cary N, Robertson, Wolfram E, Samlowski, Joel, Sheinfeld, and Donald A, Urban

Subjects
Risk Factors, Humans, Antineoplastic Agents, Prognosis, Carcinoma, Renal Cell, Nephrectomy, Kidney Neoplasms, United States, Neoplasm Staging
Published
2009

4. Testicular cancer. Clinical practice guidelines

Author

Robert J, Motzer, Robert R, Bahnson, Barry, Boston, Michael A, Carducci, Mayer, Fishman, Steven L, Hancock, Ralph J, Hauke, Gary R, Hudes, Philip, Kantoff, Timothy M, Kuzel, Paul H, Lange, Ellis G, Levine, Chris, Logothetis, Kim A, Margolin, Bruce G, Redman, Sylvia, Richey, Cary N, Robertson, Wolfram E, Samlowski, Joel, Sheinfeld, and Donald A, Urban

Subjects
Male, Young Adult, Adolescent, Testicular Neoplasms, Chemotherapy, Adjuvant, Risk Factors, Age Factors, Biomarkers, Tumor, Humans, Radiotherapy, Adjuvant, Prognosis, Neoplasm Staging, Seminoma
Published
2009

5. Bladder cancer. Clinical practice guidelines in oncology

Author

James E, Montie, Robert R, Bahnson, Samuel M, Cohen, Beverly, Drucker, Mario A, Eisenberger, Rizk, El-Galley, Harry W, Herr, Gary R, Hudes, Timothy M, Kuzel, Paul H, Lange, Anthony, Patterson, Alan, Pollack, Jerome P, Richie, John, Seigne, William U, Shipley, Eric J, Small, Donald L, Trump, Philip J, Walther, and Timothy G, Wilson

Subjects
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Chemotherapy, Adjuvant, Humans, Cystectomy, Prognosis, Neoplasm Staging
Abstract

Urothelial tumors represent a spectrum of diseases with a range of prognosis. After a diagnosis is established at any point within the urothelial tract, the patient remains at risk for developing a new lesion at a different or the same location and at a similar or more advanced stage. Continued monitoring for recurrence is an essential part of management, because most recurrences are superficial and can be managed endoscopically. Within each category of disease, more refined methods to determine prognosis and guide management, based on molecular staging, are under development with the goal of optimizing the individual patient's likelihood of cure and chance for organ preservation. For patients with more extensive disease, newer treatments typically involve combined-modality approaches, using recently developed surgical procedures, or three-dimensional treatment planning for more precise delivery of radiation therapy. Although these are not appropriate in all cases, they do offer the promise of an improved quality of life and prolonged survival. Finally, within the category of metastatic disease, a number of new agents have been identified that appear to be superior to those currently considered to be standard therapies. Experts believe, therefore, that the treatment of urothelial tumors will evolve rapidly over the next few years, with improved outcomes for patients at all stages of disease.

Published
2009

6. NCCN clinical practice guidelines in oncology: testicular cancer

Author

Robert J, Motzer, Neeraj, Agarwal, Clair, Beard, Graeme B, Bolger, Barry, Boston, Michael A, Carducci, Toni K, Choueiri, Robert A, Figlin, Mayer, Fishman, Steven L, Hancock, Gary R, Hudes, Eric, Jonasch, Anne, Kessinger, Timothy M, Kuzel, Paul H, Lange, Ellis G, Levine, Kim A, Margolin, M Dror, Michaelson, Thomas, Olencki, Roberto, Pili, Bruce G, Redman, Cary N, Robertson, Lawrence H, Schwartz, Joel, Sheinfeld, and Jue, Wang

Subjects
Male, Salvage Therapy, Testicular Neoplasms, Humans, Neoplasm Metastasis, Neoplasms, Germ Cell and Embryonal, Risk Assessment, Neoplasm Staging, Seminoma
Published
2009

7. NCCN clinical practice guidelines in oncology: kidney cancer

Author

Robert J, Motzer, Neeraj, Agarwal, Clair, Beard, Graeme B, Bolger, Barry, Boston, Michael A, Carducci, Toni K, Choueiri, Robert A, Figlin, Mayer, Fishman, Steven L, Hancock, Gary R, Hudes, Eric, Jonasch, Anne, Kessinger, Timothy M, Kuzel, Paul H, Lange, Ellis G, Levine, Kim A, Margolin, M Dror, Michaelson, Thomas, Olencki, Roberto, Pili, Bruce G, Redman, Cary N, Robertson, Lawrence H, Schwartz, Joel, Sheinfeld, and Jue, Wang

Subjects
Clinical Trials as Topic, Chemotherapy, Adjuvant, Humans, Neoplasm Metastasis, Carcinoma, Renal Cell, Combined Modality Therapy, Kidney Neoplasms, Neoplasm Staging
Published
2009

8. Bladder cancer

Author

James E. Montie, Peter E. Clark, Mario A. Eisenberger, Rizk El-Galley, Richard E. Greenberg, Harry W. Herr, Gary R. Hudes, Deborah A. Kuban, Timothy M. Kuzel, Paul H. Lange, Subodh M. Lele, Jeffrey Michalski, Anthony Patterson, Kamal S. Pohar, Jerome P. Richie, Wade J. Sexton, William U. Shipley, Eric J. Small, Donald L. Trump, Phillip J. Walther, and Timothy G. Wilson

Subjects
Male, Carcinoma, Transitional Cell, Ureteral Neoplasms, Decision Trees, Prostatic Neoplasms, Cystectomy, Kidney Neoplasms, Administration, Intravesical, Oncology, Urinary Bladder Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Humans, Kidney Pelvis, Immunotherapy
Published
2009

9. Prostate cancer. Clinical practice guidelines in oncology

Author

James, Mohler, Richard J, Babaian, Robert R, Bahnson, Barry, Boston, Anthony, D'Amico, James A, Eastham, Ralph J, Hauke, Robert P, Huben, Philip, Kantoff, Mark, Kawachi, Michael, Kuettel, Paul H, Lange, Chris, Logothetis, Gary, MacVicar, Alan, Pollack, Julio M, Pow-Sang, Mack, Roach, Howard, Sandler, Dennis, Shrieve, Sandhya, Srinivas, Przemyslaw, Twardowski, Donald A, Urban, and Patrick C, Walsh

Subjects
Male, Quality Assurance, Health Care, Humans, Prostatic Neoplasms, Medical Oncology
Published
2007

10. Point: open radical prostatectomy should not be abandoned

Author

Paul H. Lange and William J. Ellis

Subjects
Male, Prostatectomy, medicine.medical_specialty, Laparoscopic radical prostatectomy, business.industry, medicine.medical_treatment, General surgery, Urology, Prostatic Neoplasms, Tactile sensation, Surgical procedures, medicine.disease, Prostate cancer, Oncology, medicine, Humans, Lymphadenectomy, Laparoscopy, business
Abstract

Robotic-assisted laparoscopic radical prostatectomy is now one of the most common ways to treat prostate cancer. Although it is undoubtedly an outstanding procedure, in many contexts the advantages of the laparoscopic approach are overstated. The authors believe that open radical prostatectomy will continue to have an important role. For example, an extensive lymphadenectomy is more easily accomplished with the open technique and may be important in staging and possibly curing patients at high risk for prostate cancer. Also, tactile sensation is a valuable asset in assessing the extent of local tumor, and this cannot yet be replicated with a robotic approach. Furthermore, obese patients, those with a history of extensive prior surgical procedures, and men with extremely large prostates may experience advantages with the open technique. Finally, the open approach has a significant advantage in terms of hospital costs.

Published
2007

11. Kidney cancer. Clinical practice guidelines in oncology

Author

Robert J, Motzer, Graeme B, Bolger, Barry, Boston, Michael A, Carducci, Mayer, Fishman, Steven L, Hancock, Ralph J, Hauke, Gary R, Hudes, Eric, Jonasch, Philip, Kantoff, Timothy M, Kuzel, Paul H, Lange, Ellis G, Levine, Chris, Logothetis, Kim A, Margolin, Kamal, Pohar, Bruce G, Redman, Cary N, Robertson, Wolfram E, Samlowski, and Joel, Sheinfeld

Subjects
Clinical Trials as Topic, Humans, Practice Patterns, Physicians', Medical Oncology, Carcinoma, Renal Cell, Nephrectomy, Kidney Neoplasms, United States, Neoplasm Staging
Published
2006

12. Testicular cancer. Clinical practice guidelines in oncology

Author

Robert J, Motzer, Graeme B, Bolger, Barry, Boston, Michael A, Carducci, Mayer, Fishman, Steven L, Hancock, Ralph J, Hauke, Gary R, Hudes, Eric, Jonasch, Philip, Kantoff, Timothy M, Kuzel, Paul H, Lange, Ellis G, Levine, Chris, Logothetis, Kim A, Margolin, Kamal S, Pohar, Bruce G, Redman, Cary N, Robertson, Wolfram E, Samlowski, and Joel, Sheinfeld

Subjects
Male, Salvage Therapy, Clinical Trials as Topic, L-Lactate Dehydrogenase, Testicular Neoplasms, Biomarkers, Tumor, Humans, alpha-Fetoproteins, Neoplasms, Germ Cell and Embryonal, Practice Patterns, Physicians', Medical Oncology, Chorionic Gonadotropin
Published
2006

13. Bladder cancer. Clinical guidelines in oncology

Author

James E, Montie, Neil A, Abrahams, Robert R, Bahnson, Mario A, Eisenberger, Rizk, El-Galley, Harry W, Herr, Gary R, Hudes, Timothy M, Kuzel, Paul H, Lange, Anthony, Patterson, Alan, Pollack, Jerome P, Richie, Wade J, Sexton, William U, Shipley, Eric J, Small, Donald L, Trump, Phillip J, Walther, and Timothy G, Wilson

Subjects
Male, Clinical Trials as Topic, Ureteral Neoplasms, Prostatic Neoplasms, Medical Oncology, Kidney Neoplasms, Neoadjuvant Therapy, United States, Urogenital Surgical Procedures, Urinary Bladder Neoplasms, Lymphatic Metastasis, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Neoplasms, Glandular and Epithelial, Neoplasm Staging
Published
2006

Catalog

Books, media, physical & digital resources
See catalog results